Takara Accounts Payable from 2010 to 2026

TF2 Stock  EUR 6.10  0.25  4.27%   
Takara Bio's Accounts Payable is increasing over the last several years with slightly volatile swings. Accounts Payable is estimated to finish at about 1.9 B this year. Accounts Payable is the amount Takara Bio owes to suppliers or vendors for products or services received but not yet paid for. It represents Takara Bio's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2016-12-31
Previous Quarter
1.7 B
Current Value
942 M
Quarterly Volatility
560.2 M
 
Covid
 
Interest Hikes
Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
  
This module can also supplement various Takara Bio Technical models . Check out the analysis of Takara Bio Correlation against competitors.
The Accounts Payable trend for Takara Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Takara Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Takara Bio's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Takara Bio over the last few years. An accounting item on the balance sheet that represents Takara Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Takara Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Takara Bio's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takara Bio's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Takara Accounts Payable Regression Statistics

Arithmetic Mean1,741,437,255
Geometric Mean1,715,582,653
Coefficient Of Variation17.03
Mean Deviation237,757,093
Median1,690,000,000
Standard Deviation296,495,818
Sample Variance87909.8T
Range1.3B
R-Value0.33
Mean Square Error83712.5T
R-Squared0.11
Significance0.20
Slope19,229,575
Total Sum of Squares1406556.3T

Takara Accounts Payable History

20261.9 B
20251.9 B
20241.7 B
20231.5 B
20222.3 B
2021B
20202.1 B

About Takara Bio Financial Statements

Takara Bio stakeholders use historical fundamental indicators, such as Takara Bio's Accounts Payable, to determine how well the company is positioned to perform in the future. Although Takara Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Takara Bio's assets and liabilities are reflected in the revenues and expenses on Takara Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Takara Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable1.9 B1.9 B

Currently Active Assets on Macroaxis

Other Information on Investing in Takara Stock

Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.